Persistent Ductus Arteriosus: Clinical Trials

1 unknown. 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	1	Unknown 1

Follow Persistent Ductus Arteriosus: new trials by email Literature Review of Persistent Ductus Arteriosus trials Research Report on Persistent Ductus Arteriosus

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis Ibuprofen in continuous (24 hours) iv infusion and EchoG, IV bolus Ibuprofen slow (15 minutes) and EchoG - Persistent Ductus Arteriosus	Phase 3	Unknown	Instituto de Investigación Hospital Universitario La Paz	180	2017-02-20	2020-10-29

Narrower conditions

Ductus Arteriosus, Patent (1)

Broader conditions

Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Heart Defects, Congenital (1)  ·  Heart Diseases (1)

Interventions

Ibuprofen (1)  ·  Infusions, Intravenous (1)

Sponsors

Instituto de Investigación Hospital Universitario La Paz (1)

Countries

Spain (1)

NIH funding

2016 (1)